The Case for International Equities in Target-Date Funds

Most investors would jump at the chance to add more money to their portfolio, but they often fail to consider the hidden costs associated with it. These costs may not be explicit, as in the form of fees or expenses, but they can implicitly manifest as an increased level of risk.

This misunderstanding has sparked extensive discussion over the past few years as more investors focus on the surging U.S. equity market, particularly U.S. growth equities, and wonder if they have somehow “missed out” by sticking with a globally diversified portfolio.

A more concentrated portfolio of U.S. equities may make sense for some direct contribution (DC) plan participants, but for the vast majority, staying the course with a diversified approach is the right decision. While this may seem like common sense, a recent Columbia University study examined 3 million investors enrolled in 296 401(k) plans and found that most individuals are underexposed to international securities. These U.S.-concentrated portfolios have performed well of late, but they subject investors to portfolio characteristics that may not align with their objectives.

Still, it is worth noting that the past 10 years have not been as favorable to globally diversified portfolios compared with previous decades. In a recent article, Roger Aliaga-Díaz, Vanguard’s global head of portfolio construction and portfolio manager of the Target Retirement Fund series, discusses the disadvantage of chasing outperformance at the expense of portfolio diversification. As illustrated in Figure 1, Aliaga-Díaz explains how “a $100 investment in U.S. stocks 10 years ago would have grown to $334 by the end of 2024 (an annualized 13% return)—more than twice the final balance of $160 (an annualized 5% return) for a similar investment in non-U.S. stocks.”1 It is understandable that some equity investors are feeling like they are missing out.

Fig 1. Asset performance

But based on this logic, asks Aliaga-Díaz, why stop with global diversification? “The same argument could apply to all levels of portfolio diversification,” he says. “Looking at market results over the 10 years ended December 31, 2024, why bother with broadly diversified U.S. equity exposure when U.S. growth stocks outperformed the broad U.S. market by 1.4 times ($470 versus $334)? Why invest in value stocks at all?”